Vol 10: A clinician-s perspective: novel oral anticoagulants to reduce the risk of stroke in nonvalvular atrial fibrillation - full speed ahead or proceed with cautionReportar como inadecuado



 Vol 10: A clinician-s perspective: novel oral anticoagulants to reduce the risk of stroke in nonvalvular atrial fibrillation - full speed ahead or proceed with caution


Vol 10: A clinician-s perspective: novel oral anticoagulants to reduce the risk of stroke in nonvalvular atrial fibrillation - full speed ahead or proceed with caution - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Descargar gratis o leer online en formato PDF el libro: Vol 10: A clinician-s perspective: novel oral anticoagulants to reduce the risk of stroke in nonvalvular atrial fibrillation - full speed ahead or proceed with caution
This article is from Vascular Health and Risk Management, volume 10.AbstractOver the past few years, three novel oral anticoagulants, dabigatran, rivaroxaban, and apixaban, have been approved in the USA and Europe to reduce the risk of stroke or systemic embolism in patients with nonvalvular atrial fibrillation, and the results of a Phase III trial

Autor: Yang, Eugene

Fuente: https://archive.org/







Documentos relacionados